News related to
prices

The push reflects both urgency and caution. Government officials have said fertiliser stocks stand at about 18 million tonnes, up from 14.7 million tonnes a year earlier, against expected demand of roughly 39 million tonnes for the coming season. That gives policymakers some room, but not enough to ignore the exposure created by conflict near the Strait of Hormuz and tighter supply from traditional exporters. India has already been seeking larger volumes from Russia, Belarus and Morocco, while also sounding out other producers as insurance against further disruption.

At the heart of the concern is the structure of India’s import dependence. Reuters reported in March that more than 40 per cent of the country’s urea and phosphatic fertiliser needs are tied to the Middle East. Disruption there has a double effect: it threatens cargo availability and also raises the cost of natural gas, a crucial feedstock for nitrogen fertilisers. Domestic production has also come under pressure. Output of urea was reported at about 1.8 million tonnes a month during plant maintenance, below the more usual 2.4 million tonnes, adding to the need for timely imports even as officials insist there is no immediate shortage.

Price risk is now as important as volume risk. Fertiliser prices had already been climbing before the latest procurement outreach, with Reuters reporting that benchmark prices for some products rose to more than $600 a tonne from about $425. Wider market reporting has shown the same direction of travel. ICIS described March conditions as a period of heightened volatility across nitrogen, phosphate and sulphur markets as conflict in the Middle East hit trade flows and sentiment. Reuters and other industry reporting have also pointed to sharp jumps in urea and ammonia prices as shipping through Hormuz became more uncertain.

For the government, the political and economic challenge is to prevent that international surge from reaching farms at full force. Urea continues to be sold at a notified price of ₹242 for a 45-kg bag, while the Department of Fertilizers said in March that the retail price of DAP had been maintained at ₹1,350 for a 50-kg bag for the rabi season through subsidy support. That pricing shield helps farmers, but it also increases the fiscal burden when import costs rise. Industry material published in February said the state still bears about 90 per cent of the cost of urea, underlining how exposed the subsidy bill becomes when global markets tighten.

India has not relied on a single response. Apart from direct talks with overseas suppliers, firms have secured long-term volumes from Russia, including 2.8 million tonnes under reported arrangements, while a global tender for 1.3 million tonnes of urea was issued to reinforce reserves. Officials have also taken steps to support domestic output by prioritising gas allocation to fertiliser plants. The strategy suggests New Delhi is trying to build overlapping buffers rather than betting on a quick stabilisation in Gulf shipping.

The market backdrop gives that strategy added weight. Industry executives and analysts have warned that a prolonged conflict could squeeze farmers globally, alter crop choices and feed through into food inflation. Yara, one of the world’s largest fertiliser companies, has said farmers are being squeezed by the jump in input costs, while broader reporting has shown developing economies to be especially vulnerable because they are more dependent on imported fertilisers and have less room to absorb price shocks. For India, where fertiliser availability is tied directly to crop yields, rural incomes and food-price management, the issue is not only one of trade logistics but of macroeconomic stability.

By Dr. Gyan Pathak While world’s untaxed wealth of the richest 0.1 per cent hidden offshore surpasses entire wealth of the poorest half of the humanity, India remains the receiver of the highest number of the regressive tax recommendations by the International Monetary Fund (IMF) that increases tax burden on the lower-income households more than […]

The article India Gets Highest Number IMF’s Advice To Tax Lower-Income Households More appeared first on Latest India news, analysis and reports on Newspack by India Press Agency).

China’s central bank has pulled cash from the banking system for the first time in about a year, signalling a more cautious near-term approach to liquidity management as higher oil prices begin to feed into factory costs, transport bills and corporate margins.

The People’s Bank of China conducted a small reverse repo operation on 2 April while a far larger batch matured, producing a net daily withdrawal of 223.5 billion yuan. The move came after policymakers had spent months leaning towards support for growth, and it suggests Beijing is trying to preserve room for manoeuvre rather than rushing into broader easing while imported inflation risks build.

That calibration matters because China is facing two conflicting pressures at once. On one side, domestic demand remains weak, producer prices are still soft, and policymakers have already acknowledged that supply continues to outstrip demand in parts of the economy. On the other, the oil shock linked to the Middle East conflict is lifting input costs and complicating the case for an immediate flood of fresh liquidity. China’s central bank said after its first-quarter monetary policy committee meeting that it would maintain an “appropriately loose” stance while keeping liquidity ample and supporting a recovery in prices.

The timing of the drain is striking because it follows signs that parts of the economy had started to stabilise before energy costs became a bigger threat. Official manufacturing activity returned to expansion in March, with the PMI rising to 50.4 from 49.0 in February, while a private survey showed factory output and orders still growing even as cost pressures intensified. Those readings pointed to a modest improvement in momentum, but they also showed that the rebound is vulnerable to rising commodity prices and longer supplier delivery times.

Economists and policy advisers in China have begun to frame the challenge less as a choice between stimulus and restraint, and more as a balancing act between supporting growth and containing imported inflation. Huang Yiping, a central bank adviser, said this week that oil-led price pressure was hurting profitability and narrowing the room for policy to respond, even though broader inflation remains below the official target. China’s consumer inflation rose 1.3% in February, the highest in more than three years, but still below Beijing’s target of around 2% for 2026.

For markets, the signal is not that Beijing has turned hawkish. The seven-day reverse repo rate remained unchanged at 1.4%, and the central bank has continued to stress that it can still use rate cuts, reserve requirement reductions and other tools if needed. What has changed is the sequencing. Officials appear unwilling to react to every external shock with an immediate dose of easier money, especially when higher oil prices could push up headline inflation even as underlying demand stays fragile.

That caution is also tied to the broader policy picture. China set a 2026 growth target of 4.5% to 5%, below last year’s goal, reflecting weaker confidence in the external environment and the unfinished task of shifting growth away from debt-heavy sectors and towards household consumption. Policymakers have pledged to support demand, private investment and prices, but the tone from Beijing has been measured rather than aggressive. The central bank’s liquidity withdrawal fits that pattern: it does not amount to a policy reversal, but it does show a preference for targeted fine-tuning over blunt stimulus.

The oil backdrop helps explain why. China has entered the current energy shock in a stronger position than some of its Asian peers, with strategic stockpiles, diversified power supply and a large electric-vehicle base helping to soften the blow. That resilience has supported Chinese assets during wider market turbulence. Yet the country is not immune. Independent refiners have already been cutting processing rates as crude costs climb and domestic fuel demand stays under pressure, while manufacturers are reporting the fastest increase in output prices in years.

South Korea’s consumer prices rose 2.2 per cent in March from a year earlier, quickening from 2.0 per cent in both January and February as higher energy costs fed through the economy and kept inflation above the Bank of Korea’s medium-term 2 per cent target. The increase was milder than market expectations for 2.4 per cent, but it still marked the fastest annual pace since December and underscored the strain created by elevated crude prices linked to conflict-driven instability in the Middle East.

On a monthly basis, consumer prices rose 0.3 per cent in March, matching February’s pace. Petroleum products were a major driver even after Seoul introduced emergency measures to curb the blow to households and businesses. Government controls on fuel prices helped limit the pass-through, yet petroleum product prices still rose sharply from the previous month, showing how external energy shocks are overpowering domestic stabilisation efforts.

The inflation print matters because it lands at a moment when policymakers are trying to balance stronger export-led growth against mounting imported price pressures. The Bank of Korea said in its February outlook that consumer-price inflation for 2026 was expected to average 2.2 per cent, slightly above its previous 2.1 per cent forecast. That projection was made before the latest oil surge intensified, leaving economists to question whether the central bank’s assumptions have already been overtaken by events.

Core inflation, which strips out volatile food and energy items, eased slightly to 2.2 per cent in March from 2.3 per cent in February. That suggests underlying domestic demand pressures remain contained, even as headline inflation is being pushed up by imported costs. Another closely watched measure, which excludes agricultural products and petroleum, had been running at 2.5 per cent in February, indicating that sticky service-sector and household spending components have not fully disappeared.

Food prices offered some relief. Agricultural product prices fell in March as supply conditions improved, helping offset part of the jump in fuel-linked costs. That softer food picture helped explain why the overall figure came in below forecasts despite the energy shock. Still, analysts say the cushion from better farm output may prove temporary if transport, fertiliser and logistics costs keep climbing with oil.

South Korea is especially exposed because of its dependence on imported energy. About 70 per cent of its crude oil imports come from the Middle East, leaving the country vulnerable whenever shipping routes or production in the region come under threat. The government has already floated wider demand-management steps, including possible driving curbs beyond the public sector if crude prices climb further, a sign of how seriously officials are treating the supply risk.

Seoul has also moved on the fiscal side. This week the government proposed a supplementary budget of 26.2 trillion won, or about $17.3 billion, aimed at cushioning the economy from the oil shock and supporting low-income households and affected businesses. Of that, 10.1 trillion won is earmarked for measures tied to surging oil prices, including support for refiners operating under the emergency pricing system. The package highlights concern that inflation and slower consumption could combine to weaken the broader recovery.

For the central bank, the March data complicate an already delicate policy setting. The Bank of Korea’s next rate decision is due on April 10. Policymakers had held rates steady in February, and the latest inflation reading, while lower than forecast, is unlikely to offer much comfort because upside risks remain tied to oil, the exchange rate and transport costs. At the same time, softer core inflation argues against an aggressive response unless the energy shock broadens into wages and services.

The proposed tender offer price is ¥4,750 a share. That figure carries an unusual wrinkle: Reuters reported it stood 4.7% below Taiyo’s last closing price, reflecting how market speculation had already lifted the stock, while the joint company release framed the offer as carrying a steep premium to unaffected average prices before the bidding process became public and before activist-related filings stirred the shares. The contrast underlines how Japan’s take-private deals are increasingly playing out in markets already primed by rumour, activism and expectations of strategic change.

Taiyo is not a household consumer name, but it sits in businesses that have become more visible to global investors. The group is a leading producer of solder resist and other materials used in printed circuit boards and semiconductor packaging substrates, while also operating a medical and pharmaceutical arm that makes prescription drugs and provides contract development and manufacturing services. In its own long-term planning, Taiyo has pointed to growth opportunities from generative AI, data centres and communications infrastructure on the electronics side, alongside structural reform and expansion in contract manufacturing for pharmaceuticals.

That mix helps explain why KKR sees room for a private-market strategy. Taiyo said privatisation would allow it to pursue long-term investments and quicker decision-making with less pressure from the public market. The company’s “Beyond Imagination 2030” plan targets a rise in net sales to ¥180 billion by fiscal 2031 from ¥119 billion in fiscal 2025, while operating income is targeted to more than double to ¥47 billion from ¥22 billion. Management has also been trying to improve capital efficiency after sustained dialogue with shareholders, including a focus on profitability in the medical and pharmaceuticals unit and a review of portfolio positioning across the group.

For KKR, the Taiyo bid fits a broader pattern in Japan. The firm said it has been investing in the country for two decades and manages more than $20 billion there. Its existing investments span semiconductor equipment, pharmaceuticals, information technology and logistics, sectors where global funds have been seeking companies with specialised technology, export potential or scope for operational overhaul. Taiyo gives KKR exposure to electronics materials tied to advanced manufacturing as well as a pharmaceuticals platform that could benefit from demand for contract manufacturing and stable domestic drug supply.

The shareholder line-up behind the offer is also notable. DIC, Taiyo’s largest shareholder, and Kowa, which is affiliated with the founding family, have agreed to sell through a share consolidation and buyback process after the tender offer is completed. The founding family plans to reinvest in the KKR-managed vehicle that will own Taiyo after privatisation. Oasis Management, long known for active positions in Japan, has separately agreed to tender shares representing about 15.62% of the company. That combination reduces execution risk and suggests the deal has been designed to balance continuity with outside capital and governance pressure.

Still, the transaction comes with questions that investors and analysts will watch closely. A take-private at a headline valuation above ¥500 billion will invite scrutiny over whether minority holders are being offered enough upside after the stock’s sharp re-rating. The tender offer has yet to begin formally and remains subject to customary conditions, including regulatory approvals. Any delays or shifts in market conditions could test sentiment, especially at a time when deal financing and foreign buyouts in Japan are being judged against a higher bar on governance, transparency and shareholder treatment.

Taiyo’s business profile gives the story wider significance than a conventional chemicals buyout. Its electronics arm remains the core earnings driver, but the medical and pharmaceuticals business has been gaining attention as order volumes rise in contract manufacturing and as the group tries to lift margins. Taiyo’s own targets show electronics sales climbing to ¥128 billion by fiscal 2031 and medical and pharmaceuticals sales to ¥43 billion, with the latter expected to deliver a marked improvement in profitability. That combination of steady industrial demand and a healthcare growth angle is the sort of hybrid case private equity firms have been seeking across Japan’s listed mid-cap sector.